- In late February 2026, Knowles reported a fourth quarter where revenue and earnings per share exceeded analyst expectations, paired with stronger-than-expected guidance and full-year revenue growth of 7%, while also using robust cash flow to reduce debt and repurchase shares.
- Amid sector headwinds and while analysts reassess risks such as a large energy order ramp and specialty film production inefficiencies, insider stock sales by the company’s SVP and General Counsel have added another layer for investors to interpret alongside Knowles’ execution progress and capital allocation.
- We’ll now examine how this stronger-than-expected quarter and upbeat guidance could influence Knowles’ investment narrative and longer-term outlook.
The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
Knowles Investment Narrative Recap
To own Knowles, you need to believe its specialized components in medtech, defense and industrial can translate into dependable growth and improving earnings, even with modest organic revenue expectations. The latest quarter, with revenue and EPS ahead of forecasts and solid guidance, supports that thesis and helps ease concerns about margin pressure and production ramp issues in the near term, although execution around specialty films and a large energy order remains a key risk to watch.
The most relevant recent announcement here is Knowles’ strong Q4 2025 and full year 2025 print, where sales reached US$593.2 million and EPS came in above expectations, alongside healthy cash generation that funded both debt reduction and share repurchases. That combination of earnings strength and active capital returns ties directly into the current catalyst of improved profitability and balance sheet health, while sitting against the backdrop of insider selling and ongoing factory efficiency challenges.
Yet, even with a strong quarter, investors should be aware of the concentration risk around a handful of large customers and the possibility that...
Read the full narrative on Knowles (it's free!)
Knowles’ narrative projects $662.7 million revenue and $164.4 million earnings by 2028.
Uncover how Knowles' forecasts yield a $26.50 fair value, in line with its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already modeling revenue of about US$672 million and earnings near US$185 million by 2028, so this earnings beat and upbeat guidance might either reinforce that bullish view or prompt them to rethink risks like customer concentration in very different ways from the more cautious consensus.
Explore another fair value estimate on Knowles - why the stock might be worth as much as $26.50!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Knowles research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Knowles research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Knowles' overall financial health at a glance.
Searching For A Fresh Perspective?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- We've uncovered the 15 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com